Biotech Showcase Sessions

With the support of the Alzheimer's Drug Discovery Foundation (ADDF)

This collaboration brings together CTAD’s longstanding leadership and convening power in the Alzheimer’s clinical trials community with the ADDF’s scientific rigor and unique venture philanthropy model. Together, these capabilities enable the identification and elevation of the most promising innovations emerging from the biotech sector.

This year, CTAD is elevating the Biotech Showcase to a next level, reflecting the growing impact of innovation across the biotech landscape is advancing Alzheimer’s research. Hosted in the main ballroom and open to the full CTAD26 audience, these dedicated sessions bring unparalleled visibility to the most promising innovations in Alzheimer's research.

The inaugural Biotech Showcase session will kick-off with a panel of leading Alzheimer’s experts and investors, setting the stage for a thought-provoking and high-impact exchange at intersection of science, clinical development, and investment. This panel offers a unique opportunity for the research community to hear directly from investors and venture capital leaders on emerging trends, what they look for when making investment decisions and how best to attract investors.